Related Experiment Videos
Phosphorylation of DNA topoisomerase II in a human tumor cell line
1Department of Pharmacology and Therapeutics, University of Florida College of Medicine, Gainesville 32610-0267.
Abstract:
The phosphorylation of the nuclear enzyme DNA topoisomerase II was characterized from HeLa human cervical carcinoma cells labeled with 32Pi. Analysis of topoisomerase II immunoprecipitates from 32P-labeled HeLa cells indicated that phosphorylation of the enzyme occurred at serine residues. Incorporation of 32P into topoisomerase II was not due to other types of phosphomodifications such as poly(ADP-ribosylation) or covalent interactions of the enzyme with nucleic acids. The stability of topoisomerase II protein and topoisomerase II phosphorylation was also investigated in HeLa cells. Topoisomerase II protein was relatively stable, having a half-life of approximately 27 h. Phosphorylation of HeLa topoisomerase II was also remarkably stable with a T1/2 of 17 h.
Insights
This study characterized DNA topoisomerase II phosphorylation in HeLa cells, finding it occurs at serine residues. The enzyme and its phosphorylation are stable, with half-lives of 27 and 17 hours, respectively.
Area of Science:
- Molecular Biology
- Biochemistry
- Cell Biology
Background:
- DNA topoisomerase II is a crucial nuclear enzyme involved in DNA replication and repair.
- Understanding the post-translational modifications of topoisomerase II, such as phosphorylation, is vital for comprehending its function and regulation.
- HeLa cells, a well-established human cervical carcinoma cell line, serve as a model system for studying cellular processes.
Purpose of the Study:
- To characterize the phosphorylation of DNA topoisomerase II in HeLa cells.
- To identify the specific residues involved in topoisomerase II phosphorylation.
- To assess the stability of both topoisomerase II protein and its phosphorylation status.
Main Methods:
- HeLa cells were labeled with radioactive phosphorus (32P).
- Topoisomerase II was immunoprecipitated from cell lysates.
- Phosphorylation sites and stability were analyzed using biochemical techniques.
Main Results:
- Phosphorylation of DNA topoisomerase II was confirmed to occur at serine residues.
- 32P incorporation was not attributed to poly(ADP-ribosylation) or nucleic acid interactions.
- Topoisomerase II protein exhibited a half-life of approximately 27 hours.
- Phosphorylation of topoisomerase II demonstrated significant stability with a half-life of 17 hours.
Conclusions:
- DNA topoisomerase II undergoes stable serine phosphorylation in HeLa cells.
- The stability of both the enzyme and its phosphorylated form suggests a significant role in cellular processes.
- These findings contribute to the understanding of topoisomerase II regulation and function in cancer cells.